Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | FDPS | P14324 | 3/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9712731 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL11330180 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL8026611 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL3630821 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL4949893 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL22471933 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL17822464 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL2592932 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL9304805 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 | |
| SCHEMBL3634317 | 1.00 | LMNA (0.62) | LMNATSHRTHRBDNM1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1742664-A1 | PERMEATION ENHANCING COMPOSITIONS FOR ANTICHOLINERGIC AGENTS | Antares Pharma IPL AG (CH) | 2007-01-17 | — | — | EP | disclosed |
| WO-2005107812-A1 | PERMEATION ENHANCING COMPOSITIONS FOR ANTICHOLINERGIC AGENTS | ANTARES PHARMA IPL AG (CH) | 2005-11-17 | — | — | WO | disclosed |
| CN-1199947-C | Process for preparing pyridine derivatives | SANKIO CHEMICAL CO LTD (JP) | 2005-05-04 | — | — | CN | disclosed |
| CN-1402708-A | Process for production of pyridine derivs. | SANKIO CHEMICAL CO LTD (JP) | 2003-03-12 | — | — | CN | disclosed |